First, to evaluate the interaction between STAT3 and CD204 expression in the TME of cervical cancer (CC) patients, we performed double immunofluorescence staining with anti‐STAT3 and anti‐CD204 antibodies on TMA sections from 100 cervical cancer patients. This evidence concerns the gene STAT3 and cervical carcinoma.